Literature DB >> 35804217

Levetiracetam-induced myoclonus following recovery from non-convulsive status epilepticus in an elderly woman.

Megumi Nonaka1, Shuichiro Neshige2,3, Hirofumi Maruyama1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35804217     DOI： 10.1007/s11739-022-03040-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   5.472


× No keyword cloud information.
  5 in total

1.  Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies.

Authors:  Roberto H Caraballo; Ricardo Cersósimo; Cecilia De los Santos
Journal:  Epileptic Disord       Date:  2010-05-20       Impact factor: 1.819

2.  Clinical study of seven patients with special syndrome of post-epileptic dysfunction persisting over 24 hours.

Authors:  N Yang; B-G Wang; W-Y Zeng; Y Zhong; X-S Cai; L-Q Zheng; Z-Y Wu; F Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014       Impact factor: 3.507

3.  A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy.

Authors:  Karl O Nakken; Ann Sofie Eriksson; Rasmus Lossius; Svein I Johannessen
Journal:  Seizure       Date:  2003-01       Impact factor: 3.184

Review 4.  The clinical heterogeneity of drug-induced myoclonus: an illustrated review.

Authors:  Sabine Janssen; Bastiaan R Bloem; Bart P van de Warrenburg
Journal:  J Neurol       Date:  2016-12-16       Impact factor: 4.849

5.  Multifocal myoclonus as a presentation of levetiracetam toxicity.

Authors:  Mei Bou Nasif; Shweta Varade; Mohamad Z Koubeissi
Journal:  Clin Neurophysiol Pract       Date:  2021-11-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.